As German Research Center for Environmental Health, HelmholtzZentrum München (HMGU) seeks to further the development of prevention and therapy strategies for diabetes mellitus – with a special focus on personalized medicine. The Helmholtz Diabetes Center understands diabetes to be a complex, systemic disease in which both genetic and environmental factors – in particular lifestyle – interact. Here basic research and clinical research are intertwined in close interdisciplinary cooperation with the Munich universities.
Institutes and associated groups
- Institute of Diabetes Research: Prof. Dr. Ziegler, Dr. Achenbach
- Institute of Diabetes and Obesity: Prof. Dr. Tschöp, Dr. Pfluger
- Institute of Diabetes and Cancer: Prof. Dr. Stephan Herzig
- Institute of Diabetes and Regeneration Research: Prof. Dr. Lickert, Dr. Burtscher
- Institute of Experimental Genetics: Prof. Hrabě de Angelis, PD Dr. Beckers, Dr. Teperino
- Institute of Computational Biology: Prof. Fabian Theis, Dr. Jan Krumsiek (DZD-Core Unit Computational Biology)
- Clinical Cooperation Group Nutrigenomics und Typ-2-Diabetes mellitus, TUM: Prof. Dr. Hans Hauner
- Clinical Cooperation Group Prediction and Subclassification of Typ-2-Diabetes mellitus, LMU: Prof. Dr. Seissler
- Institute of Epidemiology I: Dr. Joachim Heinrich (acting)
- Institute of Epidemiology II: Prof. Dr. Peters
- Research Unit Molecular Epidemiology: Prof. Peters (acting), Dr. Grallert, Dr. Wang-Sattler
- Institute of Genetic Epidemiology: Prof. Strauch
- Institut of Health Economics and Health Care Management: Prof. Dr. Leidl, Prof. Dr. Holle
- Genom Analysis Center: Prof. Dr. Adamski
- Institute of Human Genetics: Prof. Dr. Meitinger, Dr. Strom
- Research Unit Analytical BioGeoChemistry: Prof. Dr. Schmitt-Kopplin
Contribution to the DZD research program
- Establishment and characterization of relevant mouse models
- Development of a vaccine strategy for type 1 diabetics
- Identification of early predictive metabolic markers, personalized type 2 diabetes risk prognosis
- Differentiation of embryonic stem cells into insulin-secreting cells
- Drug development
- Computational Biology
- Participation in the clinical studies of the DZD
- KORA-Cohort
Speaker

Prof. Dr. Dr. h.c.mult. Martin Hrabě de Angelis
Director of the Institute of Experimental Genetics
Helmholtz Zentrum München
Contact
Helmholtz Zentrum München – German Research Center for Environmental Health
Ingolstädter Landstrasse 1
85764 Neuherberg
Germany
+49 (0)89 3187 3302
To find out more, listen to the podcast (German only) with Professor Hrabĕ de Angelis discussing important aspects of research conducted in the DZD.